ARX:ASX
Aroa Biosurgery Ltd
A$ ०.४८
arrow_upward
+१.०४%(+०.००५०) 1D
नोभेम्बर १७, १२:०५:३३ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.४९
High
A$ ०.४९
Low
A$ ०.४८
Mkt. cap
१६.७८ करोड
Avg. vol.
२.६५ लाख
Volume
२.५४ लाख
P/E ratio
४६.२८
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.४९
High
A$ ०.४९
Low
A$ ०.४८
Mkt. cap
१६.७८ करोड
Avg. vol.
२.६५ लाख
Volume
२.५४ लाख
P/E ratio
४६.२८
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
Stocktwits
·
१ घण्टा पहिले
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
ChartMill
·
५ घण्टा पहिले
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
११ घण्टा पहिले
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
१ घण्टा पहिले
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd